Cardinal Health Inc. (CAH)
CAH Stocks Gains on Q1 Earnings & Sales Beat and Raised '25 EPS View
Cardinal Health's first-quarter fiscal 2025 results benefit from solid Pharmaceutical and Specialty Solutions growth. However, OptumRx contract expiry hurts sales.
Here's What Key Metrics Tell Us About Cardinal (CAH) Q1 Earnings
The headline numbers for Cardinal (CAH) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Cardinal Health (CAH) Q1 Earnings and Revenues Beat Estimates
Cardinal Health (CAH) came out with quarterly earnings of $1.88 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $1.73 per share a year ago.
Cardinal Health lifts annual profit outlook on strength in specialty medicines unit
Cardinal Health raised its 2025 adjusted profit forecast on Friday as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit, sending the shares of the company up nearly 4% in premarket trading.
Exploring Analyst Estimates for Cardinal (CAH) Q1 Earnings, Beyond Revenue and EPS
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Cardinal (CAH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.
Cardinal Health (CAH) Stock Sinks As Market Gains: Here's Why
In the most recent trading session, Cardinal Health (CAH) closed at $110.87, indicating a -0.02% shift from the previous trading day.
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cardinal Health to Report Q1 Earnings: What's in Store?
Cardinal Health, Inc. CAH is scheduled to report fiscal first-quarter 2025 results on Nov. 1, before the opening bell.
Here's Why Cardinal Health (CAH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal Health (CAH) Stock Dips While Market Gains: Key Facts
In the closing of the recent trading day, Cardinal Health (CAH) stood at $111.92, denoting a -0.52% change from the preceding trading day.
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
